Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
María José GarcíaSabino RiestraAurélien AmiotMette JulsgaardIrene García de la FiliaMargalida CalafatMariam AguasLuisa de la PeñaCristina RoigBerta CaballolMaría José CasanovaKlaudia FarkasTrine BoysenLuis BujandaCamila CuaránDaniela DobruFotios FousekisCarla Jerusalén Gargallo-PuyueloEdoardo SavarinoXavier CalvetJose Maria HuguetLimas KupcinskasJulia López-CardonaTim RaineJoep van OostromFrancisco Javier García-AlonsoMaria ChaparroPublished in: Alimentary pharmacology & therapeutics (2024)
Third-line rescue treatment avoided colectomy in over half of the patients with ASUC and may be considered a therapeutic strategy.